David Rosenberg and Jörg Thomaier were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Rosenberg and Thomaier were featured in the legal section, as LSIPR reports.
Name: David Rosenberg
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
David Rosenberg, Jörg Thomaier, GSK, intellectual property, patent, esearch and development, Bayer, trademark, licensing,